Anti-viral T-cell Therapy by Gamma Capture

Clinical trial NCT06027879 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06027879
Sponsor: Paul Szabolcs
Status: ENROLLING_BY_INVITATION
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Adenovirus Cytomegalovirus Infections Epstein-Barr Virus Infections

Start date: 2024-01-08
Primary completion: 2028-06-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.